Pharmacokinetics of Panaxynol in Mice.

Tashkandi, Hossam; Chaparala, Anusha; Peng, Sean; Nagarkatti, Mitzi; Nagarkatti, Prakash; Chumanevich, Alexander A; Hofseth, Lorne J

Tashkandi, Hossam; Chaparala, Anusha; Peng, Sean; Nagarkatti, Mitzi; Nagarkatti, Prakash; Chumanevich, Alexander A; Hofseth, Lorne J.

Afiliación

Tashkandi H; Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.
Chaparala A; OB/GYN, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Peng S; Touchstone Biosciences, Plymouth Meeting, PA, USA.
Nagarkatti M; Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29208, USA.
Nagarkatti P; Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29208, USA.
Chumanevich AA; Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.
Hofseth LJ; Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.

J Cancer Sci Clin Ther ; 4(2): 133-143, 2020.

Article en En | MEDLINE | ID: mdl-32905447

Palabras clave

Bioavailability; Falcarinol; Ginseng; Half-life; Mice; Panaxynol; Pharmacokinetics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Cancer Sci Clin Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google